Bottom line
How much do PJP and FTXH overlap?
43% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 46.8% of PJP's assets and 54.7% of FTXH's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PJP and FTXH have in common
| Holding | % of PJP | % of FTXH | Overlap |
|---|---|---|---|
| AbbVie Inc. | 5.48% | 7.39% | 5.48% |
| Amgen Inc. | 5.33% | 3.18% | 3.18% |
| Johnson & Johnson | 5.18% | 6.96% | 5.18% |
| Merck & Co., Inc. | 5.06% | 7.07% | 5.06% |
| Eli Lilly and Co. | 5.02% | 7.77% | 5.02% |
| Gilead Sciences, Inc. | 4.53% | 2.89% | 2.89% |
| Pfizer Inc. | 4.50% | 2.97% | 2.97% |
| Regeneron Pharmaceuticals, Inc. | 3.14% | 2.72% | 2.72% |
| Bristol-Myers Squibb Co. | 2.94% | 6.29% | 2.94% |
| Viatris Inc. | 2.83% | 3.62% | 2.83% |
| Biogen Inc. | 2.75% | 3.84% | 2.75% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PJP
- Invesco Private Prime Fund — 7.93%
- Abbott Laboratories — 5.67%
- Corcept Therapeutics Inc. — 4.96%
- Amneal Pharmaceuticals, Inc. — 3.75%
- Invesco Private Government Fund — 3.73%
- Liquidia Corp. — 3.66%
- Travere Therapeutics, Inc. — 3.30%
- Ligand Pharmaceuticals Inc. — 3.20%
- Harmony Biosciences Holdings, Inc. — 3.06%
- Jazz Pharmaceuticals PLC — 2.79%
- Collegium Pharmaceutical, Inc. — 2.74%
- Prestige Consumer Healthcare Inc. — 2.74%
- Ocular Therapeutix, Inc. — 2.58%
- ANI Pharmaceuticals, Inc. — 2.55%
Only in FTXH
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- United Therapeutics Corp — 2.72%
- Jazz Pharmaceuticals Plc — 2.49%
- Incyte Corp — 2.39%
- Illumina Inc — 1.98%
- Zoetis Inc — 1.87%
- Exelixis Inc — 1.72%
- Charles River Laboratories International Inc — 1.49%
- Medpace Holdings Inc — 1.41%
- Ptc Therapeutics Inc — 1.37%
- Neurocrine Biosciences Inc — 1.37%
- Alkermes Plc — 1.35%
- Halozyme Therapeutics Inc — 1.21%
Asset mix
| Asset type | PJP | FTXH |
|---|---|---|
| Stocks | 99.9% | 99.9% |
| Cash & short-term funds | 11.8% | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | PJP | FTXH |
|---|---|---|
| US | 106.5% | 95.6% |
| IE | 5.2% | 3.8% |
| BM | — | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do PJP and FTXH overlap?
What stocks do PJP and FTXH have in common?
Should I own both PJP and FTXH?
Which holds more stocks, PJP or FTXH?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.